SYLVIA PHOMMALINH: Open Payments
NPI 1598240731 · GILBERT, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$5,546 in 346 payments from 22 companies in 2025. Trend: 2023 $4,700 · 2024 $7,687 · 2025 $5,546
Food & beverage: $5,546
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 90 | $1,219 |
| Amgen Inc. | 72 | $1,105 |
| UCB, Inc. | 31 | $622 |
| Janssen Biotech, Inc. | 33 | $567 |
| AstraZeneca Pharmaceuticals LP | 23 | $438 |
| PFIZER INC. | 18 | $339 |
| Novartis Pharmaceuticals Corporation | 30 | $282 |
| Mallinckrodt Hospital Products Inc. | 9 | $204 |
| Radius Health, Inc. | 8 | $142 |
| Organon LLC | 8 | $132 |
Products named: RINVOQ, Bimzelx, TREMFYA, SKYRIZI, XELJANZ, KRYSTEXXA, COSENTYX, Otezla.
Industry payments across AZ — which companies pay providers there.
